We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole.
- Authors
Patel, Nayankumar H.; Sardana, Kabir; Shenoy, Manjunath M.; Rengasamy, Madhu; Khurana, Ananta; Ghate, Sunil; Venkata, Chalam Konakanchi; Marfatiya, Yogesh; Bhunia, Deblina; Jayaraman, Jyothi; Das, Anupam; Jain, Akshay Kumar
- Abstract
Itraconazole (ITZ) has been the mainstay of oral antifungal treatment for the current epidemic of recalcitrant dermatophytosis (RD) in India. Recently, a newer formulation of ITZ, super bioavailable itraconazole (SUBA-ITZ), is made available in the market by many pharmaceutical companies. It is important for dermatologists to understand the pharmacokinetic properties of SUBA-ITZ vis-a-vis conventional pellet formulation to use it effectively and safely. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) has established a special interest group for recalcitrant dermatophytosis (SIG-RD) to strengthen research, continuing medical education, and industry collaboration on the subject. This position statement on SUBA-ITZ by SIG-RD is an attempt to address current pieces of evidence and the position of this new formulation in the management of RD.
- Subjects
INDIA; RINGWORM; ITRACONAZOLE; CONTINUING medical education; ORAL drug administration
- Publication
Indian Dermatology Online Journal, 2024, Vol 15, Issue 1, p1
- ISSN
2229-5178
- Publication type
Article
- DOI
10.4103/idoj.idoj_668_22